In this issue:
EULAR recommendations for treating systemic sclerosis
ACR guideline for screening, treatment, and management of lupus nephritis
The diagnosis and management of Still's disease
Recommendations on biologic and targeted synthetic disease modifying antirheumatic drugs
Physical activity and self-management of pain during transitional care
Diagnosis and management of antiphospholipid syndrome
Medicine shortages in Rheumatology in 2024: key concerns
Steqeyma (ustekinumab) approved by the TGA
Pharmaceutical Benefits Advisory Committee (BPAC) outcomes
New open-access journal launched by the EULAR
Guideline scope for pain management in people with inflammatory arthritis
Phase 3 results for deucravacitinib in adults with psoriatic arthritis
Freeze on release of health information from United States Government
Please login below to download this issue (PDF)